Year: 2014
New study shows counting calories works best for weight loss: How to benefit
EC does not exercise its authority to curb vote rigging: Sujan
Exercise, Interrupted | debby weighs in
Exercise those ears: Simple ways to keep your hearing in shape
4 cases of Ebola turn up in Guinea’s capital
As U.S. momentum stocks take beating, some sectors benefit
By Ryan Vlastelica and David Gaffen NEW YORK (Reuters) – Investors in some of the past year's hottest U.S. stocks have been given a savage lesson in the risks of so-called "momentum trading". A group of 24 such companies compiled by Credit Suisse has lost $63 billion in market value, or almost 19 percent, so far in March. One of them, streaming video service Netflix, has declined on 15 of the last 17 trading days, while another, online travel service Priceline, is on pace to for its worst month in nearly two years, while Twitter on Wednesday sank below its November first-day closing price for the first time since December, when the company had publicly traded for less than a month. The sell off may well have further to go, investors warn.
Banish the Diet
Study finds many preteens have high cholesterol
Eating Small And In Intervals May Not Always Help In Weight Loss!
GSK lifts emerging market bet with full control of Indonesia arm
GlaxoSmithKline is betting more on Indonesia by taking full control of its consumer healthcare unit in the country, underscoring a drive by the drugmaker to build up its presence in fast-growing emerging markets. GSK has paid 465 billion rupiahs ($40 million) to Sarasvati Venture Capital for the 30 percent of the Indonesian consumer healthcare operation it did not previously own, giving it 100 percent of a business that sells non-prescription products like Panadol painkillers and Sensodyne toothpaste. At the same time, GSK has sold its non-core local Insto eye drops brand to Pharma Healthcare and agreed to divest its factory at Bogor, Indonesia, to PT Pharma Healthcare for a combined total of 133 billion rupiahs. "This transaction is a further example of GSK focusing its business in strategically important growth markets such as Indonesia.
North Korea envoy tells U.N. rights forum ‘mind your own business’
North Korea's ambassador told the United Nations Human Rights Council on Friday to "mind your own business" during a debate on crimes against humanity documented in his country by U.N. investigators. So Se Pyong, North Korea's ambassador to the U.N. in Geneva, speaking in response to unprecedented criticism of its human rights record, also said that "cooperation can never be compatible with confrontation".